ArticleJournal of clinical medicine2026

Intravitreal Brolucizumab for Diabetic Macular Edema: Outcomes in Treatment-Naive and Anti-VEGF-Switched Eyes over 48 Weeks.

Fumiaki Higashijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.